Paclitaxel-loaded ROS-responsive nanoparticles for head and neck cancer therapy

References

• Abu Samaan TM, Samec M, Liskova A, et al. (2019). Paclitaxel’s mechanistic and clinical effects on breast cancer. Biomolecules 9:1.
   Web of Science ®Google Scholar
• Bao Y, Guo Y, Zhuang X, et al. (2014). D-alpha-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells. Mol Pharmaceutics 11:3196–12.
   PubMed Web of Science ®Google Scholar
• Bao Y, Yin M, Hu X, et al. (2016). A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery. J Control Release 235:182–94.
   PubMed Web of Science ®Google Scholar
• Bertrand N, Wu J, Xu X, et al. (2014). Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev 66:2–25.
   PubMed Web of Science ®Google Scholar
• Cheng TM, Chang WJ, Chu HY, et al. (2021). Nano-strategies targeting the integrin alphavbeta3 network for cancer therapy. Cells 10:1684.
   PubMed Web of Science ®Google Scholar
• Chiang JL, Yang YW. (2021). Modulation of the anticancer activities of paclitaxel by Cremophor micelles. Int J Pharm 603:120699.
   PubMedGoogle Scholar
• Cui H, Arnst K, Miller DD, Li W. (2020). Recent advances in elucidating paclitaxel resistance mechanisms in non-small cell lung cancer and strategies to overcome drug resistance. CMC 27:6573–95.
   Google Scholar
• Fang J, Nakamura H, Maeda H. (2011). The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 63:136–51.
   PubMed Web of Science ®Google Scholar
• Gong Z, Liu X, Zhou B, et al. (2021). Tumor acidic microenvironment-induced drug release of RGD peptide nanoparticles for cellular uptake and cancer therapy. Colloids Surf B Biointerfaces 202:111673.
   PubMed Web of Science ®Google Scholar
• Guan Y, Wang LY, Wang B, et al. (2020). Recent advances of D-alpha-tocopherol polyethylene Glycol 1000 succinate based stimuli-responsive nanomedicine for cancer treatment. Curr Med SCI 40:218–31.
   PubMed Web of Science ®Google Scholar
• Guo Y, Luo J, Tan S, et al. (2013). The applications of vitamin E TPGS in drug delivery. Eur J Pharm Sci 49:175–86.
   PubMed Web of Science ®Google Scholar
• Haider M, Elsherbeny A, Jagal J, et al. (2020). Optimization and evaluation of poly(lactide-co-glycolide) nanoparticles for enhanced cellular uptake and efficacy of paclitaxel in the treatment of head and neck cancer. Pharmaceutics 12:828.
   PubMed Web of Science ®Google Scholar
• Iyer AK, Khaled G, Fang J, Maeda H. (2006). Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today 11:812–8.
   PubMed Web of Science ®Google Scholar
• Li R, Peng F, Cai J, et al. (2020). Redox dual-stimuli responsive drug delivery systems for improving tumor-targeting ability and reducing adverse side effects. Asian J Pharm Sci 15:311–25.
   PubMed Web of Science ®Google Scholar
• Li Z, Gao Y, Li W, et al. (2022a). Charge-reversal nanomedicines as a smart bullet for deep tumor penetration. Smart Mater Med 3:243–53.
   Google Scholar
• Li Z, Yang Y, Wei H, et al. (2021). Charge-reversal biodegradable MSNs for tumor synergetic chemo/photothermal and visualized therapy. J Control Release 338:719–30.
   PubMed Web of Science ®Google Scholar
• Li Z, Yu Y, Zeng W, et al. (2022a). Mussel-inspired ligand clicking and ion coordination on 2D black phosphorus for cancer multimodal imaging and therapy. Small 18:e2201803.
   PubMed Web of Science ®Google Scholar
• Liang C, Wang H, Zhang M, et al. (2018). Self-controlled release of oxaliplatin prodrug from d-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) functionalized mesoporous silica nanoparticles for cancer therapy. J Colloid Interface Sci 525:1–10.
   PubMed Web of Science ®Google Scholar
• Liang J, Yang B, Zhou X, et al. (2021). Stimuli-responsive drug delivery systems for head and neck cancer therapy. Drug Deliv 28:272–84.
   PubMed Web of Science ®Google Scholar
• Lippert AR, Van de Bittner GC, Chang CJ. (2011). Boronate oxidation as a bioorthogonal reaction approach for studying the chemistry of hydrogen peroxide in living systems. Acc Chem Res 44:793–804.
   PubMed Web of Science ®Google Scholar
• Luo C, Sun J, Liu D, et al. (2016). Self-assembled redox dual-responsive prodrug-nanosystem formed by single thioether-bridged paclitaxel-fatty acid conjugate for cancer chemotherapy. Nano Lett 16:5401–8.
   PubMed Web of Science ®Google Scholar
• Min S, Jeon YS, Jung HJ, et al. (2020). Independent Tuning of nano-ligand frequency and sequences regulates the adhesion and differentiation of stem cells. Adv Mater 32:e2004300.
   PubMed Web of Science ®Google Scholar
• Mollazadeh S, Mackiewicz M, Yazdimamaghani M. (2021). Recent advances in the redox-responsive drug delivery nanoplatforms: a chemical structure and physical property perspective. Mater Sci Eng C Mater Biol Appl 118:111536.
   PubMed Web of Science ®Google Scholar
• Saravanakumar G, Kim J, Kim WJ. (2017). Reactive-oxygen-species-responsive drug delivery systems: promises and challenges. Adv Sci). 4:1600124.
   Web of Science ®Google Scholar
• Sheppard N. (1950). The vibrational spectra of some organic sulphur compounds and the characteristic frequencies of C-S linkages. Trans Faraday Soc 46:429–39.
   Google Scholar
• Song W, Tang Z, Zhang D, et al. (2014). Anti-tumor efficacy of c(RGDfK)-decorated polypeptide-based micelles co-loaded with docetaxel and cisplatin. Biomaterials 35:3005–14.
   PubMed Web of Science ®Google Scholar
• Sun T, Zhang YS, Pang B, et al. (2014). Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed Engl 53:12320–64.
   PubMed Web of Science ®Google Scholar
• Sun Y, Kang C, Liu F, et al. (2017). RGD peptide-based target drug delivery of doxorubicin nanomedicine. Drug Dev Res 78:283–91.
   PubMed Web of Science ®Google Scholar
• Tan C, Fan H, Ding J, et al. (2022). ROS-responsive nanoparticles for oral delivery of luteolin and targeted therapy of ulcerative colitis by regulating pathological microenvironment. Mater Today Bio 14:100246.
   PubMedGoogle Scholar
• Tan S, Zou C, Zhang W, et al. (2017). Recent developments in d-alpha-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy. Drug Deliv 24:1831–42.
   PubMed Web of Science ®Google Scholar
• Tan SW, Zhao D, Yuan DQ, et al. (2011). Influence of indomethacin-loading on the micellization and drug release of thermosensitive dextran-graft-poly(N-isopropylacrylamide). Reactive & Functional Polymers 71:820–7.
   Web of Science ®Google Scholar
• Tao W, He Z. (2018). ROS-responsive drug delivery systems for biomedical applications. Asian J Pharm Sci 13:101–12.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Okamoto K, Yodoi J, Hiai H. (1995). Persistent oxidative stress in cancer. FEBS Lett 358:1–3.
   PubMed Web of Science ®Google Scholar
• Wu N, Tu Y, Fan G, et al. (2022). Enhanced photodynamic therapy/photothermo therapy for nasopharyngeal carcinoma via a tumour microenvironment-responsive self-oxygenated drug delivery system. Asian J Pharm Sci 17:253–67.
   PubMed Web of Science ®Google Scholar
• Yang C, Wu T, Qi Y, Zhang Z. (2018). Recent advances in the application of vitamin E TPGS for drug delivery. Theranostics 8:464–85.
   PubMed Web of Science ®Google Scholar
• Youk HJ, Lee E, Choi MK, et al. (2005). Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol. J Control Release 107:43–52.
   PubMed Web of Science ®Google Scholar
• Zhang C, Shang Y, Chen X, et al. (2020). Supramolecular nanofibers containing arginine-glycine-aspartate (RGD) peptides boost therapeutic efficacy of extracellular vesicles in kidney repair. ACS Nano 14:12133–47.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tan S, Feng SS. (2012). Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials 33:4889–906.
   PubMed Web of Science ®Google Scholar
• Zhao S, Tan S, Guo Y, et al. (2013). pH-sensitive docetaxel-loaded D-alpha-tocopheryl polyethylene glycol succinate-poly(beta-amino ester) copolymer nanoparticles for overcoming multidrug resistance. Biomacromolecules 14:2636–46.
   PubMed Web of Science ®Google Scholar